Juan Sierra

High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment.

Á. L. Fernández, J. González-Juanatey, M. Couselo-Seijas, 2019, Atherosclerosis.

Modification of Carbon Nanotubes with Electronegativity Molecules to Control the Adhesion of Low Density Lipoprotein

A. García, Juan Sierra, Jesús Antonio Carlos Cornelio, 2016 .

Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells

Á. Fernández-Trasancos, R. Lage, J. González-Juanatey, 2015, Molecular and Cellular Endocrinology.

Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease

Á. Fernández-Trasancos, J. González-Juanatey, R. Agra, 2014, Inflammation.

Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression.

S. Eiras, A. Salgado-Somoza, J. R. Juanatey, 2010, Cytokine.

Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease

Á. Fernández-Trasancos, J. González-Juanatey, R. Agra, 2014, Inflammation.

Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat.

Á. Fernández-Trasancos, J. González-Juanatey, D. Pascual-Figal, 2014, Life sciences.